Evidence map›Paper›PMID 35366801›Full record

Trial reportBMC anesthesiology2022

Comparison of left double lumen tube and y-shaped and double-ended bronchial blocker for one lung ventilation in thoracic surgery-a randomised controlled clinical trial.

Joachim Risse, Karsten Szeder, Ann-Kristin Schubert, Thomas Wiesmann, Hanns-Christian Dinges, Carsten Feldmann, Hinnerk Wulf, Karl Matteo Meggiolaro

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC anesthesiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. [Application and Research Progress of Video Double-lumen Tube in Thoracic Surgery].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2022
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Joachim RisseCenter of Emergency Medicine, University Hospital Essen, Essen, Germany.
Karsten SzederDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany.
Ann-Kristin SchubertDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany.
Thomas WiesmannDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany.
Hanns-Christian DingesDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany.
Carsten FeldmannDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany.
Hinnerk WulfDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany.
Karl Matteo MeggiolaroDepartment of Anesthesiology and Intensive Care Medicine, Philipps-University, Marburg, Germany. meggiola@med.uni-marburg.de.
Philipps University of Marburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDouble lumen tube (DLT) intubation is the most commonly used technique for one lung ventilation. Bronchial blockers (BB) are an alternative, especially for difficult airways. The EZ-bronchial blocker (EZB) is an innovative y-shaped and double-ended device of the BB family.

methodsA randomised, controlled trial was conducted in 80 patients undergoing elective thoracic surgery using DLT or EZB for one lung ventilation (German Clinical Trial Register DRKS00014816). The objective of the study was to compare the clinical performance of EZB with DLT. Primary endpoint was total time to obtain successful one lung ventilation. Secondary endpoints were time subsections, quality of lung collapse, difficulty of intubation, any complications during the procedure, incidence of objective trauma of the oropharynx and supraglottic space and intubation-related subjective symptoms.

results74 patients were included, DLT group (n = 38), EZB group (n = 36). Median total time to obtain one lung ventilation [IQR] in the DLT group was 234 s [207 to 294] versus 298 s [243 to 369] in the EZB group (P = 0.007). Median total time was relevantly influenced by different preparation times. Quality of lung collapse was equal in both groups, DLT group 89.5% were excellent vs. 83.3% in the EZB group (P = 0.444). Inadequate lung collapse in five patients of the EZB group resulted in unsuccessful repositioning attempts and secondary DLT placement. Endoscopic examinations revealed significantly more carina trauma (P = 0.047) and subglottic haemorrhage (P = 0.047) in the DLT group. Postoperative subjective symptoms (sore throat, hoarseness) were more common in the DLT group, as were speech problems.

conclusionsUsing EZB prima facie results in prolonged time to obtain one lung ventilation with equal quality of lung collapse for the thoracic surgeon. If preparation times are omitted in the analysis, the time difference is statistically and clinically not relevant. Our data showed only little evidence for reducing objective airway trauma as well as subjective complaints. In summary both procedures were comparable in terms of times and clinical applicability. Therefore decisions for DLT or EZB should depend more on individual experience, in-house equipment and the individual patient, than on any times that are neither clinically significant nor relevant.

trial registrationGerman Clinical Trial Register DRKS00014816 , prospectively registered on 07.06.2018.

Indexed as

One-Lung VentilationThoracic SurgeryThoracic Surgical ProceduresBronchiHumansIntubation, IntratrachealLeft double lumen tubeOne lung ventilationThoracic surgeryY-shaped-bronchial blocker

Identifiers

PMID35366801
PMCPMC8976407
OpenAlexW4226281410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.